I'm going to assume you want me particularly to address the issue of tamper-resistant medication. Again, sometimes these things aren't entirely intuitive. Your first gut reaction might be that if we can provide a tamper-resistant drug, then that should be what we should enforce. Having said that, sometimes you have to dig a little deeper into the evidence. One thing I'm pleased about is that we're able to provide a comprehensive approach to drug policy. That comprehensive approach includes a number of things like educating prescribers, the public, the health workforce. It also includes making sure that we minimize the harms to people.
But on the matter of tamper resistant, something very interesting happened. In 2012 the first products of tamper-resistant Oxycontin were introduced into the market. As a result of that most provincial drug policies, not all, but most provincial plans included only the tamper-resistant version. What ended up happening around the same time, and this has been well documented, was a rise in the illicit use of other substances, particularly fentanyl, which is now our number one problem in the country.